DelveInsight Business Research LLP

DelveInsight’s “Ventral Hernia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Ventral Hernia, historical and forecasted epidemiology as well as the Ventral Hernia market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Ventral Hernia Overview

A ventral (abdominal) hernia refers to any protrusion of the intestine or other tissue through a weakness or gap in the abdominal wall. Umbilical and incisional hernias are specific types of ventral hernias.

Ventral Hernia Epidemiology Insights

Mean age of presentation among 71 patients (27 males, 44 females) was 48.11±5.71 years. Incisional hernias (30.98%) were the commonest type. Painless swelling (49.29%) was the most common clinical presentation. Obesity (40.84%) and multiparity (30.98%) were the most common associated risk factors. Incisional hernias are probably better managed by open approach.

Click here to learn more about the Ventral Hernia Market Landscape

The Report Covers the Ventral Hernia Epidemiology Segmented by:

• Ventral Hernia  total prevalent cases 

• Ventral Hernia  total diagnosed cases 

• Ventral Hernia total incident cases 

• Ventral Hernia treatment cases 

Ventral Hernia Market Outlook 

The Ventral Hernia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Ventral Hernia market trends by analyzing the impact of current Ventral Hernia therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Ventral Hernia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Ventral Hernia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Ventral Hernia market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Ventral Hernia Market

• Medtronic 

• CR Bard 

• AbbVie 

• Tela Bio Inc 

• Ethicon Inc 

And many others 

Ventral Hernia Therapies Covered and Analyzed in the Report:

• BOTOX Dose A

• CA-008 (vocacapsaicin)

• INL-001

• Citrulline

• Acetaminophen

And many others 

Learn more about the Key Companies and Emerging Therapies in the Ventral Hernia  Market

Table of Contents 

1. Key Insights 

2. Ventral Hernia  Introduction 

3. Executive Summary of Ventral Hernia   

4. Disease Background and Overview

5. Epidemiology and patient population

6. Ventral Hernia  Emerging Therapies

7. Ventral Hernia  Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Ventral Hernia Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services